nct_id,nlm_download_date_description,study_first_submitted_date,results_first_submitted_date,disposition_first_submitted_date,last_update_submitted_date,study_first_submitted_qc_date,study_first_posted_date,study_first_posted_date_type,results_first_submitted_qc_date,results_first_posted_date,results_first_posted_date_type,disposition_first_submitted_qc_date,disposition_first_posted_date,disposition_first_posted_date_type,last_update_submitted_qc_date,last_update_posted_date,last_update_posted_date_type,start_month_year,start_date_type,start_date,verification_month_year,verification_date,completion_month_year,completion_date_type,completion_date,primary_completion_month_year,primary_completion_date_type,primary_completion_date,target_duration,study_type,acronym,baseline_population,brief_title,official_title,overall_status,last_known_status,phase,enrollment,enrollment_type,source,limitations_and_caveats,number_of_arms,number_of_groups,why_stopped,has_expanded_access,expanded_access_type_individual,expanded_access_type_intermediate,expanded_access_type_treatment,has_dmc,is_fda_regulated_drug,is_fda_regulated_device,is_unapproved_device,is_ppsd,is_us_export,biospec_retention,biospec_description,ipd_time_frame,ipd_access_criteria,ipd_url,plan_to_share_ipd,plan_to_share_ipd_description,created_at,updated_at,intervention_type,intervention_name,description,intervention_count,status,facility_name,city,state,zip,country,site_count
NCT04308187,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-12,NA,NA,2020-03-12,2020-03-12,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-12,2020-03-13,Actual,"March 11, 2020",Anticipated,2020-03-11,March 2020,2020-03-31,March 2022,Anticipated,2022-03-31,March 2022,Anticipated,2022-03-31,1 Day,Observational [Patient Registry],COVISTRESS,,Influence of the COvid-19 Epidemic on STRESS,The COVISTRESS Study: Influence of the COvid-19 Epidemic on STRESS,Not yet recruiting,NA,NA,50000,Anticipated,"University Hospital, Clermont-Ferrand",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:20:07Z,2020-04-01T09:20:07Z,NA,NA,NA,NA,,"University Hospital, Clermont-Ferrand",Clermont-Ferrand,,63000,France,1
NCT04314271,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-16,NA,NA,2020-03-16,2020-03-16,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-16,2020-03-19,Actual,"March 20, 2020",Anticipated,2020-03-20,March 2020,2020-03-31,"May 31, 2020",Anticipated,2020-05-31,"May 1, 2020",Anticipated,2020-05-01,3 Weeks,Observational [Patient Registry],NA,,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Recruiting,NA,NA,80,Anticipated,Xiangya Hospital of Central South University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:19:19Z,2020-04-01T09:19:19Z,NA,NA,NA,NA,Recruiting,"Xiangya Hospital, Central South University",Changsha,Hunan,410000,China,1
NCT04318314,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-17,NA,NA,2020-03-25,2020-03-19,2020-03-23,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-26,Actual,"March 18, 2020",Actual,2020-03-18,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2020",Anticipated,2020-12-31,6 Months,Observational [Patient Registry],COVID19-HCW,,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Recruiting,NA,NA,400,Anticipated,"University College, London",,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood samples Nasal and oropharygeal swabs
    ",NA,NA,NA,Yes,Publication of results in open access journals; sharing of results in scientific databases.,2020-04-03T09:20:28Z,2020-04-03T09:20:28Z,Diagnostic Test,COPAN swabbing and blood sample collection,COPAN swabbing of nostrils and/or oropharynx and blood sample collection,1,"Recruiting|Active, not recruiting",Barts Heart Center|Royal Free London NHS Foundation Trust,London|London,|,|,United Kingdom|United Kingdom,2
NCT04315870,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-18,NA,NA,2020-03-19,2020-03-19,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-19,2020-03-20,Actual,"January 1, 2020",Actual,2020-01-01,March 2020,2020-03-31,"April 30, 2020",Anticipated,2020-04-30,"April 20, 2020",Anticipated,2020-04-20,3 Months,Observational [Patient Registry],I-COVID,,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy,Recruiting,NA,NA,20,Anticipated,Federico II University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not decided yet,2020-04-01T09:19:07Z,2020-04-01T09:19:07Z,Other,pregnant women with laboratory-confirmed 2019-n-CoV,Clinical records and compiled data of all consecutive hospitalized and outpatient pregnant women with laboratory-confirmed 2019-n-CoV were included in a merged database,1,Recruiting,University of Naples Federico II,Napoli,,80100,Italy,1
NCT04319016,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-30,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"January 1, 2020",Actual,2020-01-01,March 2020,2020-03-31,"May 1, 2020",Anticipated,2020-05-01,"April 30, 2020",Anticipated,2020-04-30,3 Months,Observational [Patient Registry],COVID-preg,,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Recruiting,NA,NA,20,Anticipated,Federico II University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not planned yet,2020-04-03T09:20:02Z,2020-04-03T09:20:02Z,Other,pregnant women with laboratory-confirmed 2019-n-CoV,Clinical records and compiled data of all consecutive hospitalized and outpatient pregnant women with laboratory-confirmed 2019-n-CoV were included in a merged database,1,Recruiting,Gabriele Saccone,Napoli,,80129,Italy,1
NCT04320472,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-22,NA,NA,2020-03-30,2020-03-22,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,December 2020,Anticipated,2020-12-31,December 2020,Anticipated,2020-12-31,3 Months,Observational [Patient Registry],NeuroCOVID19,,Acute Encephalopathy in Critically Ill Patients With SARS-Cov-2 Infection,Outcomes in Patients With Acute Encephalopathy and SARS-Cov-2 Infection,Recruiting,NA,NA,250,Anticipated,Ictal Group,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:19:11Z,2020-04-03T09:19:11Z,Other,Follow up,"Follow up up to day 90 (Glasgow outcome scale, functionnal impairments)",1,Recruiting,Centre Hospitalier de Versailles,Le Chesnay,,78150,France,1
NCT04321811,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-23,NA,NA,2020-03-30,2020-03-24,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-02,Estimate,"March 21, 2020",Actual,2020-03-21,March 2020,2020-03-31,"March 20, 2022",Anticipated,2022-03-20,"March 20, 2021",Anticipated,2021-03-20,1 Year,Observational [Patient Registry],BEAT19,,"Behavior, Environment And Treatments for Covid-19",A PATIENT-CENTRIC OUTCOMES REGISTRY OF PATIENTS WITH KNOWN OR SUSPECTED NOVEL CORONAVIRUS INFECTION SARS-COV-2 (COVID-19),Recruiting,NA,NA,100000,Anticipated,xCures,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,De-identified datasets will be made available to qualified researchers in accordance with the study protocol.,2020-04-03T09:18:20Z,2020-04-03T09:18:20Z,Other,"Observation of patients with known, suspected, or at risk for COVID-19 infection",Participants will receive daily diary surveys to track the symptomatic course of known or suspected COVID-19 patients as well as use of any interventions or treatments.,1,Recruiting,BEAT19.org,San Francisco,California,94022,United States,1
NCT04323839,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-24,NA,NA,2020-03-24,2020-03-24,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-24,2020-03-27,Actual,"March 20, 2020",Actual,2020-03-20,March 2020,2020-03-31,"March 31, 2024",Anticipated,2024-03-31,"March 31, 2024",Anticipated,2024-03-31,12 Months,Observational [Patient Registry],PRIORITY,,PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),PRIORITY (Pregnancy Coronavirus Outcomes Registry),Recruiting,NA,NA,1000,Anticipated,"University of California, San Francisco",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:17:05Z,2020-04-03T09:17:05Z,Other|Other,Pregnant women under investigation for Coronavirus or diagnosed with COVID-19|Postpartum women under investigation for Coronavirus or diagnosed with COVID-19,This is an observational study with no intervention|This is an observational study with no intervention,2,Recruiting,"University of California, San Francisco",San Francisco,California,94143,United States,1
NCT04325048,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-25,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,September 2021,Anticipated,2021-09-30,June 2021,Anticipated,2021-06-30,2 Months,Observational [Patient Registry],NA,,Clinical Evaluation of Cordio Application in Adult COVID19 Virus Positive Patients,Single-Arm Observational Study Designed to Clinically Evaluate Cordio Application in Adult Patients Positive to COVID19,Not yet recruiting,NA,NA,5000,Anticipated,Cordio Medical,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:16:24Z,2020-04-03T09:16:24Z,Device,Cordio App,Adult patients positive to COVID19 virus will record several predefined sentences via a smartphone / tablet and will answer questions via the app,1,NA,NA,NA,NA,NA,NA,NA
NCT04325412,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-25,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,"June 23, 2021",Anticipated,2021-06-23,"March 23, 2021",Anticipated,2021-03-23,30 Days,Observational [Patient Registry],CAPACITY-COVID,,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Recruiting,NA,NA,1000,Anticipated,UMC Utrecht,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:16:12Z,2020-04-03T09:16:12Z,NA,NA,NA,NA,Recruiting,University Medical Center Utrecht,Utrecht,,3584 CX,Netherlands,1
NCT04323878,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-28,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-28,2020-03-31,Actual,"April 6, 2020",Anticipated,2020-04-06,March 2020,2020-03-31,"November 9, 2020",Anticipated,2020-11-09,"October 5, 2020",Anticipated,2020-10-05,1 Month,Observational [Patient Registry],EC-COVID-PCS,,Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,EC-COVID-PCS - Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,Not yet recruiting,NA,NA,3000,Anticipated,Mario Negri Institute for Pharmacological Research,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:17:04Z,2020-04-03T09:17:04Z,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NCT04327570,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-26,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-31,Actual,"March 27, 2020",Anticipated,2020-03-27,March 2020,2020-03-31,"September 30, 2020",Anticipated,2020-09-30,"September 30, 2020",Anticipated,2020-09-30,6 Months,Observational [Patient Registry],COntAGIouS,,In-depth Immunological Investigation of COVID-19.,In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2,Not yet recruiting,NA,NA,100,Anticipated,Universitaire Ziekenhuizen Leuven,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood, plasma, PBMC, BAL, lung tissue
    ",NA,NA,NA,Undecided,NA,2020-04-03T09:14:46Z,2020-04-03T09:14:46Z,Other,Patient sampling,"Blood draw, NP/rectal swab, bronchoscopy if clinically indicated, lung tissue if applicable",1,NA,NA,NA,NA,NA,NA,NA
NCT04327479,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-26,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-31,Actual,"March 26, 2020",Actual,2020-03-26,March 2020,2020-03-31,"March 25, 2026",Anticipated,2026-03-25,"March 25, 2026",Anticipated,2026-03-25,1 Year,Observational [Patient Registry],NA,,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Recruiting,NA,NA,6000,Anticipated,"University Hospital, Essen",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Will be made available upon request,2020-04-03T09:14:49Z,2020-04-03T09:14:49Z,Diagnostic Test,Assessment of cardiovascular diseases and cardiovascular risk factors,"At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.",1,Recruiting,University Hospital Essen,Essen,NRW,45147,Germany,1
NCT04327674,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-27,NA,NA,2020-03-30,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 14, 2020",Actual,2020-03-14,March 2020,2020-03-31,"May 15, 2020",Anticipated,2020-05-15,"May 15, 2020",Anticipated,2020-05-15,1 Month,Observational [Patient Registry],NA,,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Recruiting,NA,NA,375,Anticipated,University of Aarhus,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:14:43Z,2020-04-03T09:14:43Z,NA,NA,NA,NA,Recruiting|Recruiting,Lungemedicinsk Forskningsafdeling. Aarhus University Hospital|Regionshospitalet Horsens.,Aarhus|Horsens,|,8000|,Denmark|Denmark,2
NCT04329559,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-29,NA,NA,2020-03-29,2020-03-29,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-29,2020-04-01,Actual,"March 30, 2020",Actual,2020-03-30,March 2020,2020-03-31,"June 29, 2021",Anticipated,2021-06-29,"June 29, 2020",Anticipated,2020-06-29,1 Year,Observational [Patient Registry],NA,,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,NA,NA,50,Anticipated,Hepatopancreatobiliary Surgery Institute of Gansu Province,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:13:33Z,2020-04-03T09:13:33Z,NA,NA,NA,NA,Not yet recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Not yet recruiting|Recruiting|Recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Recruiting|Recruiting,"Dalian Sixth People's Hospital|Minda Hospital Affiliated to Hubei University for Nationalities|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture|The First Hospital of Lanzhou University|The Central Hospital of Lishui City|Guangxi Zhuang Autonomous Region|The Sixth Peoples Hospital of Shenyang|Shenzhen Third People's Hospital|Suizhou Hospital, Hubei University of Medicine|Tianjin Second People's Hospital|Ankang Central Hospital|Renmin Hospital of Wuhan University|Wuhan Union Hospital|Xingtai People's Hospital|The Affiliated Third Hospital of Jiangsu University",Dalian|Enshi|Enshi|Lanzhou|Lishui|Nanning|Shenyang|Shenzhen|Suizhou|Tianjin|Wuhan|Wuhan|Wuhan|Xingtai|Zhenjiang,||||||||||||||,||||||||||||||,China|China|China|China|China|China|China|China|China|China|China|China|China|China|China,15
NCT04331860,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-30,NA,NA,2020-03-31,2020-03-31,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-02,Estimate,"March 30, 2020",Actual,2020-03-30,March 2020,2020-03-31,"March 30, 2025",Anticipated,2025-03-30,"March 30, 2025",Anticipated,2025-03-30,5 Years,Observational [Patient Registry],C19REG,,COVID-19 Public Image Registry,COVID-19 Public Image Registry,Recruiting,NA,NA,500000,Anticipated,RAD-AID International,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"All data will be shared, but in a de-identified state.",2020-04-03T09:12:13Z,2020-04-03T09:12:13Z,Other,No intervention,"There is no intervention, this is an observational registry",1,Recruiting,To be determined,San Francisco,California,94960,United States,1
NCT04331574,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-30,NA,NA,2020-04-01,2020-04-01,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-02,Estimate,"March 10, 2020",Actual,2020-03-10,April 2020,2020-04-30,"April 30, 2020",Anticipated,2020-04-30,"April 10, 2020",Anticipated,2020-04-10,3 Months,Observational [Patient Registry],SARS-RAS,,Renin-Angiotensin System Inhibitors and COVID-19,Phase IV Observational Study to Associate Hypertension and Hypertensinon Treatment to COVID19,Recruiting,NA,NA,2000,Anticipated,Societa Italiana dell'Ipertensione Arteriosa,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:12:22Z,2020-04-03T09:12:22Z,NA,NA,NA,NA,Recruiting,Spedali Civili di Brescia,Brescia,,,Italy,1
NCT04331171,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-30,NA,NA,2020-03-30,2020-03-30,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-02,Estimate,"March 17, 2020",Actual,2020-03-17,March 2020,2020-03-31,"July 31, 2020",Anticipated,2020-07-31,"March 31, 2020",Anticipated,2020-03-31,1 Day,Observational [Patient Registry],COVID CALL 15,,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Recruiting,NA,NA,15000000,Anticipated,Weprom,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:12:34Z,2020-04-03T09:12:34Z,Device,Web application users,questionnaire of comorbidity and symptoms completed by the patient on his smartphone,1,Recruiting,All French Emergency services,Le Mans,,,France,1
